Gilead Sciences stock has room to climb, and investors shouldn’t overlook the company’s impressive record in navigating HIV policy, Citi Research says. Analysts led by Geoff Meacham reiterated a Buy ...

Citigroup said it’s “very bullish” on Gilead’s HIV franchise, arguing it’s the drugmaker’s biggest value driver as the company’s new ...

Celebrities and beauty editors rarely turn to the same skincare brand for the same product, but the Elemis Cleansing Balm ...

While we love the Augustinus Bader The Rich Cream, we do love the price. Depending on the size, you can spend anywhere from ...

--(BUSINESS WIRE)-- Gilead Sciences, Inc. (Nasdaq: GILD) today announced the presentation of late-breaking data and multiple oral presentations from its innovative HIV treatment portfolio and pipeline ...

I have recently endured several years of difficult life adjustments. I noticed an improvement in both my mood and outlook when I started referring to this time of my life as an “uncomfortable ...

[3] If you have been looking to nail down that homemade lip balm for pink lips then go ahead and try this super easy rose lip balm recipe. Melt beeswax and coconut oil together in a double boiler.

Men as allies in advancing women’s political participation” that he delivered in Ado Ekiti on Monday during a one-day HeForShe Conference organised by the Balm in Gilead Foundation for ...

"What is the church doing? What is the faith community doing?” asked the Rev. Evatt Mugarura, director of Balm in Gilead in Africa. “The churches have resources. The churches have voices,” he added.

Valued at a market cap of $143.8 billion, Gilead Sciences, Inc. (GILD) is a biopharmaceutical company that discovers, develops, and commercializes medicines in the areas of unmet medical need.

Novartis' Kymriah has had the CAR-T therapy market for acute lymphoblastic leukaemia (ALL) to itself so far, but Gilead Sciences' Kite subsidiary is now looming in the rear view mirror – armed ...